Document is current
Any future updates will be listed below
-
Authors
Blum, Claudine A. https://orcid.org/0000-0003-0487-5587
Velly, Laëtitia
Brochet, Christine https://orcid.org/0000-0002-9086-9847
Ziegler, Frédéric
Tavolacci, Marie-Pierre https://orcid.org/0000-0003-3980-819X
Hausfater, Pierre
Lvovschi, Virginie Eve https://orcid.org/0000-0003-2903-1911
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01975753 at ClinicalTrials.govDocuments that mention this clinical trial
Relevance of cortisol and copeptin blood concentration changes in an experimental pain model
https://doi.org/10.1038/s41598-022-08657-4
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2BSP3_155212)
Novo Nordisk
Thermo Fisher Scientific
Ministère des Affaires Sociales et de la Santé (Programme Hospitalier de Recherche Clinique 2012)
- License Information
-
More Information
Article History
Received: 20 August 2021
Accepted: 3 March 2022
First Online: 19 March 2022
Competing interests
: C. A. B. received an unrestricted research grant from Novo Nordisk. ThermoFisher SA, the manufacturer of the copeptin assay, provided the assays for copeptin measurements. PH has received lectures and educational honorarium from ThermoFisher Scientific and bioMérieux unrelated to this study. All other authors have no competing interest linked to the whole trial.
